Literature DB >> 32493166

Long Range Endocrine Delivery of Circulating miR-210 to Endothelium Promotes Pulmonary Hypertension.

Jonathan Florentin1, Yi-Yin Tai1, Thomas Bertero2, Partha Dutta1,3, Stephen Y Chan1,3, Jingsi Zhao1, Stéphanie Torrino2, Lee Ohayon1, Tomasz Brzoska1, Ying Tang1, Jimin Yang1, Vinny Negi1, Chen-Shan Chen Woodcock1, Michael G Risbano1,4, Seyed Mehdi Nouraie1,4, Prithu Sundd1,4.   

Abstract

RATIONALE: Unproven theories abound regarding the long-range uptake and endocrine activity of extracellular blood-borne microRNAs into tissue. In pulmonary hypertension (PH), microRNA-210 (miR-210) in pulmonary endothelial cells promotes disease, but its activity as an extracellular molecule is incompletely defined.
OBJECTIVE: We investigated whether chronic and endogenous endocrine delivery of extracellular miR-210 to pulmonary vascular endothelial cells promotes PH. METHODS AND
RESULTS: Using miR-210 replete (wild-type [WT]) and knockout mice, we tracked blood-borne miR-210 using bone marrow transplantation and parabiosis (conjoining of circulatory systems). With bone marrow transplantation, circulating miR-210 was derived predominantly from bone marrow. Via parabiosis during chronic hypoxia to induce miR-210 production and PH, miR-210 was undetectable in knockout-knockout mice pairs. However, in plasma and lung endothelium, but not smooth muscle or adventitia, miR-210 was observed in knockout mice of WT-knockout pairs. This was accompanied by downregulation of miR-210 targets ISCU (iron-sulfur assembly proteins)1/2 and COX10 (cytochrome c oxidase assembly protein-10), indicating endothelial import of functional miR-210. Via hemodynamic and histological indices, knockout-knockout pairs were protected from PH, whereas knockout mice in WT-knockout pairs developed PH. In particular, pulmonary vascular engraftment of miR-210-positive interstitial lung macrophages was observed in knockout mice of WT-knockout pairs. To address whether engrafted miR-210-positive myeloid or lymphoid cells contribute to paracrine miR-210 delivery, we studied miR-210 knockout mice parabiosed with miR-210 WT; Cx3cr1 knockout mice (deficient in myeloid recruitment) or miR-210 WT; Rag1 knockout mice (deficient in lymphocytes). In both pairs, miR-210 knockout mice still displayed miR-210 delivery and PH, thus demonstrating a pathogenic endocrine delivery of extracellular miR-210.
CONCLUSIONS: Endogenous blood-borne transport of miR-210 into pulmonary vascular endothelial cells promotes PH, offering fundamental insight into the systemic physiology of microRNA activity. These results also describe a platform for RNA-mediated crosstalk in PH, providing an impetus for developing blood-based miR-210 technologies for diagnosis and therapy in this disease.

Entities:  

Keywords:  endothelium; lymphocytes; macrophage; microRNAs; parabiosis

Mesh:

Substances:

Year:  2020        PMID: 32493166      PMCID: PMC7429300          DOI: 10.1161/CIRCRESAHA.119.316398

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  47 in total

Review 1.  Clinical application of remote ischemic preconditioning.

Authors:  Robert A Kloner
Journal:  Circulation       Date:  2009-02-17       Impact factor: 29.690

2.  Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation.

Authors:  Sathish Babu Vasamsetti; Jonathan Florentin; Emilie Coppin; Lotte C A Stiekema; Kang H Zheng; Muhammad Umer Nisar; John Sembrat; David J Levinthal; Mauricio Rojas; Erik S G Stroes; Kang Kim; Partha Dutta
Journal:  Immunity       Date:  2018-06-26       Impact factor: 31.745

3.  Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs.

Authors:  Makon-Sébastien Njock; Henry S Cheng; Lan T Dang; Maliheh Nazari-Jahantigh; Andrew C Lau; Emilie Boudreau; Mark Roufaiel; Myron I Cybulsky; Andreas Schober; Jason E Fish
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

4.  Remote cardioprotection by transfer of coronary effluent from ischemic preconditioned rabbit heart preserves mitochondrial integrity and function via adenosine receptor activation.

Authors:  Chung Ho Leung; Lixing Wang; Jan M Nielsen; Michael B Tropak; Yana Y Fu; Hideyuki Kato; John Callahan; Andrew N Redington; Christopher A Caldarone
Journal:  Cardiovasc Drugs Ther       Date:  2014-02       Impact factor: 3.727

5.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.

Authors:  Jason D Arroyo; John R Chevillet; Evan M Kroh; Ingrid K Ruf; Colin C Pritchard; Donald F Gibson; Patrick S Mitchell; Christopher F Bennett; Era L Pogosova-Agadjanyan; Derek L Stirewalt; Jonathan F Tait; Muneesh Tewari
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

6.  Inhibition of microRNA-210 suppresses pro-inflammatory response and reduces acute brain injury of ischemic stroke in mice.

Authors:  Lei Huang; Qingyi Ma; Yong Li; Bo Li; Lubo Zhang
Journal:  Exp Neurol       Date:  2017-10-27       Impact factor: 5.330

7.  Remote ischemic preconditioning elaborates a transferable blood-borne effector that protects mitochondrial structure and function and preserves myocardial performance after neonatal cardioplegic arrest.

Authors:  Lixing Wang; Norihiko Oka; Michael Tropak; John Callahan; John Lee; Greg Wilson; Andrew Redington; Christopher A Caldarone
Journal:  J Thorac Cardiovasc Surg       Date:  2008-06-02       Impact factor: 5.209

8.  p66ShcA modulates tissue response to hindlimb ischemia.

Authors:  Germana Zaccagnini; Fabio Martelli; Pasquale Fasanaro; Alessandra Magenta; Carlo Gaetano; Anna Di Carlo; Paolo Biglioli; Marco Giorgio; Ines Martin-Padura; Pier Giuseppe Pelicci; Maurizio C Capogrossi
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

9.  Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210.

Authors:  Haopeng Wang; Henrik Flach; Michio Onizawa; Lai Wei; Michael T McManus; Arthur Weiss
Journal:  Nat Immunol       Date:  2014-03-09       Impact factor: 25.606

10.  TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.

Authors:  Rahul Kumar; Claudia Mickael; Biruk Kassa; Liya Gebreab; Jeffrey C Robinson; Daniel E Koyanagi; Linda Sanders; Lea Barthel; Christina Meadows; Daniel Fox; David Irwin; Min Li; B Alexandre McKeon; Suzette Riddle; R Dale Brown; Leslie E Morgan; Christopher M Evans; Daniel Hernandez-Saavedra; Angela Bandeira; James P Maloney; Todd M Bull; William J Janssen; Kurt R Stenmark; Rubin M Tuder; Brian B Graham
Journal:  Nat Commun       Date:  2017-05-30       Impact factor: 14.919

View more
  9 in total

1.  Endocrine Delivery of MicroRNA-210: A Trusted Traveler That Mediates Pulmonary Hypertension.

Authors:  Jane A Leopold
Journal:  Circ Res       Date:  2020-08-13       Impact factor: 17.367

2.  MicroRNA-210 Mediates Hypoxia-Induced Repression of Spontaneous Transient Outward Currents in Sheep Uterine Arteries During Gestation.

Authors:  Xiang-Qun Hu; Chiranjib Dasgupta; Rui Song; Monica Romero; Sean M Wilson; Lubo Zhang
Journal:  Hypertension       Date:  2021-03-01       Impact factor: 10.190

Review 3.  Endothelial cells in the pathogenesis of pulmonary arterial hypertension.

Authors:  Colin E Evans; Nicholas D Cober; Zhiyu Dai; Duncan J Stewart; You-Yang Zhao
Journal:  Eur Respir J       Date:  2021-09-02       Impact factor: 33.795

4.  ADAR1 RNA editing regulates endothelial cell functions via the MDA-5 RNA sensing signaling pathway.

Authors:  Xinfeng Guo; Silvia Liu; Rose Yan; Vy Nguyen; Mazen Zenati; Timothy R Billiar; Qingde Wang
Journal:  Life Sci Alliance       Date:  2021-12-30

5.  Computational repurposing of therapeutic small molecules from cancer to pulmonary hypertension.

Authors:  Vinny Negi; Jimin Yang; Gil Speyer; Andres Pulgarin; Adam Handen; Jingsi Zhao; Yi Yin Tai; Ying Tang; Miranda K Culley; Qiujun Yu; Patricia Forsythe; Anastasia Gorelova; Annie M Watson; Yassmin Al Aaraj; Taijyu Satoh; Maryam Sharifi-Sanjani; Arun Rajaratnam; John Sembrat; Steeve Provencher; Xianglin Yin; Sara O Vargas; Mauricio Rojas; Sébastien Bonnet; Stephanie Torrino; Bridget K Wagner; Stuart L Schreiber; Mingji Dai; Thomas Bertero; Imad Al Ghouleh; Seungchan Kim; Stephen Y Chan
Journal:  Sci Adv       Date:  2021-10-20       Impact factor: 14.136

Review 6.  Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension.

Authors:  Laurent Calvier; Joachim Herz; Georg Hansmann
Journal:  JACC Basic Transl Sci       Date:  2022-02-28

7.  miR-210-3p protects against osteoarthritis through inhibiting subchondral angiogenesis by targeting the expression of TGFBR1 and ID4.

Authors:  Han Tang; Wenrun Zhu; Lu Cao; Jin Zhang; Juncheng Li; Duan Ma; Changan Guo
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

8.  Circulating hypoxia-dependent miR-210 is increased in clinical sepsis subtypes: A cohort study.

Authors:  Rachel E Powell; Yi Yin Tai; Jason N Kennedy; Christopher W Seymour; Stephen Y Chan
Journal:  J Transl Med       Date:  2022-10-04       Impact factor: 8.440

Review 9.  The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease.

Authors:  Lee Ohayon; Xinyi Zhang; Partha Dutta
Journal:  Pharmacol Res       Date:  2021-06-25       Impact factor: 10.334

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.